Sodium Glucose Cotransporter 2 Inhibition by Canagliflozin Attenuates Intrarenal Angiotensinogen Augmentation in Type 2 Diabetes Mellitus.

被引：0
|
作者：
Woods, T. Cooper [1 ]
Satou, Ryousule [1 ]
Miyata, Kayoko [1 ]
Katsurada, Akemi [1 ]
Dugas, Courtney M. [1 ]
Lightell, Daniel, Jr. [1 ]
Navar, L. Gabriel [1 ]
机构：
[1] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
来源：
HYPERTENSION | 2017年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
AP464
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus
    Kambara, Takahiro
    Shibata, Rei
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    Murohara, Toyoaki
    Ajioka, Masayoshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (01) : 108 - 114
  • [32] The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
    Xu, Bo
    Li, Shaoqian
    Kang, Bo
    Zhou, Jiecan
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [33] Discovery of Canagliflozin, a Novel C-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Nomura, Sumihiro
    Sakamaki, Shigeki
    Hongu, Mitsuya
    Kawanishi, Eiji
    Koga, Yuichi
    Sakamoto, Toshiaki
    Yamamoto, Yasuo
    Ueta, Kiichiro
    Kimata, Hirotaka
    Nakayama, Keiko
    Tsuda-Tsukimoto, Minoru
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (17) : 6355 - 6360
  • [34] Alterations of Glucose Metabolism in Type 2 Diabetes Mellitus. An Overview
    Riccardo C. Bonadonna
    Reviews in Endocrine and Metabolic Disorders, 2004, 5 : 89 - 97
  • [35] Alterations of glucose metabolism in type 2 diabetes mellitus. An overview
    Bonadonna, RC
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2004, 5 (02): : 89 - 97
  • [36] Glucose metabolism in elderly patients with type 2 diabetes mellitus.
    Paty, BW
    Finegood, D
    D'Alessio, DA
    Meneilly, GS
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 77A - 77A
  • [37] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
    Mahling, Moritz
    Schork, Anja
    Nadalin, Silvio
    Fritsche, Andreas
    Heyne, Nils
    Guthoff, Martina
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05): : 984 - 992
  • [38] EFFECTS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR, CANAGLIFLOZIN ON GLOMERULAR HYPERFILTRATION AND OXIDATIVE STRESS IN MICE WITH TYPE 2 DIABETES
    Kondo, Megumi
    Kidokoro, Kengo
    Wada, Yoshihisa
    Tokuyama, Atsuyuki
    Kadoya, Hiroyuki
    Sasaki, Tamaki
    Kashihara, Naoki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 26 - 26
  • [39] Sodium-glucose cotransporter 2 inhibitors for treating diabetes mellitus
    Goldberg, Nicola
    Fralick, Michael
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (20) : E724 - E724
  • [40] Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus
    Nair, Sunil
    Wilding, John P. H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 34 - 42
12345